Republicans, Democrats and the public at large agree that prices for prescription drugs are too high. But no one seems to know how to fix it. Vanderbilt University drug price researcher Stacie Dusetzina explains the basics of why drugs cost so much and why it’s hard to do something about it. Joanne Kenen of Politico, Sarah Karlin-Smith of the Pink Sheet and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the prospects for policy changes.
Federal officials asked a court to dismiss a suit by drugmakers over the policy enacted by the Trump administration that would allow states to bring in cheaper prescription medications from Canada. The filing said the lawsuit was moot because it’s unclear when or if the FDA would approve any state’s importation plan.
The University of Miami Health System charges a truck driver six times what Medicare would pay for an overnight test.
Covid-caused delays in medical treatments and surgeries are producing data for health care providers to take another look at what’s needed and what isn’t.
Dentists know how to maximize the profits in your mouth. But sometimes it’s outright fraud — to the tune of billions every year.
Patients often fork over payments comparable to valet rates to park while receiving care. A recent study found that some of the country’s most prestigious cancer centers charge nearly $1,700 over the course of treatment for some types of the disease.
Democratic leaders in Congress have vowed to pass legislation to address high prescription drug prices this year, but some moderates in their own party appear to be balking. Meanwhile, younger teens are now eligible for a covid-19 vaccine and the Biden administration reinstated anti-discrimination policy for LGBTQ people in health care. Joanne Kenen of Politico, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.
The costs of personal protective equipment and disinfecting offices while seeing fewer patients have some doctors and dentists demanding that insurance companies step up.
It’s time to consider primary care a “common good” akin to public education and shore up the foundation of the pandemic-battered U.S. health system, report says.
After a year of uncharacteristically being on the same page when it comes to health care, Democratic lawmakers are at loggerheads about what to do next. Most agree the time is ripe to tackle high drug prices. But they divide over whether to take savings from that to move to a ‘Medicare for All’ insurance system, enhance the current Medicare program or strengthen benefits under the Affordable Care Act.
